Plasma plasminogen activator inhibitor-1 as a predictive marker of type 2 diabetic nephropathy in Egyptian patients

Plasma plasminogen activator inhibitor-1 as a predictive marker of type 2 diabetic nephropathy in Egyptian patients

Background The study investigates the relationship between Plasminogen activator inhibitor-1 (PAI-1) levels and the progression of diabetic nephropathy (DN). The fibrinolytic system is impaired in type 2 diabetes mellitus (DM), leading to elevated PAI-1 levels, increasing the potential for renal fib...

Descripció completa

Dades bibliogràfiques
Autors principals: El-Saeid M.E.-S. El-Bawab, Mostafa M.M. Alomairi, Ashraf M. El- Kabeer, Sayed F.A. Abd-Allah
Format: Article
Idioma:English
Publicat: Wolters Kluwer Medknow Publications 2023-07-01
Col·lecció:Al-Azhar Assiut Medical Journal
Matèries:
diabetic nephropathy
end-stage renal disease
fibrinolytic system
plasminogen activator inhibitor-1
renal fibrosis
type 2 diabetes mellitus
Accés en línia:https://journals.lww.com/10.4103/azmj.azmj_22_24

Internet

https://journals.lww.com/10.4103/azmj.azmj_22_24

Ítems similars